Actual conversion rate from total mastectomy to breast conservation after neoadjuvant chemotherapy for stages II-III breast cancer patients

被引：0
|
作者：
Mo, H. [1 ]
Kim, Y. [1 ]
Rhu, J. [1 ]
Lee, K. H. [2 ]
Kim, T. Y. [2 ]
Im, S. A. [2 ]
Lee, E. S. [1 ]
Lee, H. B. [1 ]
Moon, H. G. [1 ]
Noh, D. Y. [1 ]
Han, W. [1 ]
机构：
[1] Seoul Natl Univ, Coll Med, Dept Surg, Seoul, South Korea
[2] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea
来源：
EUROPEAN JOURNAL OF CANCER | 2018年 / 92卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
295 (PB-09
引用
收藏
页码：S80 / S80
页数：1
相关论文
共 50 条
  • [41] Surgical conservation planning after neoadjuvant chemotherapy for stage II and operable stage III breast carcinoma
    Kuerer, HM
    Singletary, SE
    Buzdar, AU
    Ames, FC
    Valero, V
    Buchholz, TA
    Ross, MI
    Pusztai, L
    Hortobagyi, GN
    Hunt, KK
    AMERICAN JOURNAL OF SURGERY, 2001, 182 (06): : 601 - 608
  • [42] Neoadjuvant trastuzumab in a sequential nonanthracycline-based regimen for patients with stage II-III breast cancer
    Carillio, G.
    Aiello, R.
    Ali, M.
    Mazzola, A.
    Scandurra, G.
    Taibi, E.
    Chiarenza, M.
    Fallica, G.
    Caruso, F.
    Caruso, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [43] Cyclin E as a prognostic marker and predictor of response to neoadjuvant chemotherapy and adjuvant hormonal therapy in patients with stage II-III breast cancer
    Karakas, Cansu
    Francis, Ashleigh
    Yi, Min
    Sahin, Aysegul
    Keyomarsi, Khandan
    Hunt, Kelly
    CANCER RESEARCH, 2015, 75
  • [44] Adjuvant FOLFOX Chemotherapy and Splenomegaly in Patients with Stages II-III Colorectal Cancer
    Angitapalli, Revathi
    Litwin, Alan M.
    Kumar, Prasanna R. G.
    Nasser, Eiad
    Lombardo, Jeffrey
    Mashtare, Terry
    Wilding, Gregory E.
    Fakih, Marwan G.
    ONCOLOGY, 2009, 76 (05) : 363 - 368
  • [45] Clinical outcomes according to molecular subtypes in stage II-III breast cancer patients treated with neoadjuvant chemotherapy followed by surgery and radiotherapy
    Kim, Hakyoung
    Park, Won
    Huh, Seung Jae
    Choi, Doo Ho
    Noh, Jae Myoung
    Im, Young-Hyuck
    Ahn, Jin Seok
    Park, Yeon Hee
    Nam, Seok Jin
    Kim, Seok Won
    Lee, Jeong Eon
    Cho, Eun Yoon
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2017, 13 (04) : 329 - 336
  • [46] Analysis of circulating tumor DNA after neoadjuvant therapy to predict disease relapse in patients with stage II-III breast cancer
    Lin, Po-Han
    Kuo, Sung-Sheng
    Huang, Chiun-Sheng
    CANCER RESEARCH, 2020, 80 (16)
  • [47] The Role of Postmastectomy Radiation Therapy for Clinical Stage II-III Breast Cancer Patients With Pathological Complete Remission of Axillary Lymph Nodes After Neoadjuvant Chemotherapy
    Luo, J.
    Chen, X.
    Yang, Z.
    Zhang, L.
    Mei, X.
    Ma, J.
    Zhang, Z.
    Shao, Z.
    Yu, X.
    Guo, X.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : E33 - E33
  • [48] The sequencing of chemotherapy and radiotherapy in breast cancer patients after mastectomy
    Kim, Hak Jae
    Kim, Jae-Sung
    Chie, Eui Kyu
    Noh, Dong-young
    Bang, Yung-jue
    Ha, Sung Whan
    TUMORI JOURNAL, 2010, 96 (01): : 28 - 33
  • [49] The sequencing of chemotherapy and radiotherapy in breast cancer patients after mastectomy
    Kim, J-S.
    Kim, H. J.
    Chie, E. K.
    Ha, S. W.
    RADIOTHERAPY AND ONCOLOGY, 2006, 81 : S291 - S291
  • [50] The role of postmastectomy radiotherapy in clinically node-positive, stage II-III breast cancer patients with pathological negative nodes after neoadjuvant chemotherapy: an analysis from the NCDB
    Liu, Jieqiong
    Mao, Kai
    Jiang, Shuai
    Jiang, Wen
    Chen, Kai
    Kim, Betty Y. S.
    Liu, Qiang
    Jacobs, Lisa K.
    ONCOTARGET, 2016, 7 (17) : 24848 - 24859
12345